510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K253710Substantially Equivalent

Dexcom G7 Continuous Glucose Monitoring (CGM) System, Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System

Dexcom, Inc., San Diego CA / Special, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K253710 is the FDA 510(k) clearance record for Dexcom G7 Continuous Glucose Monitoring (CGM) System, Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System, a class II device, cleared for Dexcom, Inc. on under FDA product code QBJ (Integrated Continuous Glucose Monitoring System, Factory Calibrated). FDA's definition for product code QBJ reads: "An integrated continuous glucose monitoring system (iCGM) is intended to automatically measure glucose in bodily fluids continuously or frequently for a specified period of time. iCGM systems are designed to reliably and securely transmit...". FDA records list 28 510(k) clearances for Dexcom, Inc., from to . As of , FDA records show no recalls naming K253710.

Clearance record

Decision date
Received
(23 days to decision)
Product code
QBJ Integrated Continuous Glucose Monitoring System, Factory Calibrated
Regulation
21 CFR 862.1355
Device class
Class II
Review panel
Clinical Chemistry
Applicant
Dexcom, Inc. 6340 Sequence Dr., San Diego CA
510(k) summary
Summary PDF
Third party review
No

Clearances, product code QBJ

Trailing 12 months
3 clearances under product code QBJ in the twelve months to October 2026, December 2025 the highest month at 1.
Show the numbers
Monthly 510(k) clearances under FDA product code QBJ, trailing twelve months
MonthClearances
November 20250
December 20251
January 20260
February 20261
March 20260
April 20260
May 20260
June 20261
July 20260
August 20260
September 20260
October 20260